Study identifier:NIS-CKR-CRE-2007/2
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
RUSH (Evaluating the efficacy of RosUvaStatin for Korean dyslipidemia patients with Hypertension in real world practice)
Dyslipidemia
-
Yes
-
All
5000
Observational
18 Years +
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Nov 2010 by AstraZeneca Pharmaceuticals
AstraZeneca Pharmaceuticals
-
No locations available
Arms | Assigned Interventions |
---|